ATE380816T1 - Substituierte imidazopyrimidine zur prävention und behandlung von krebs - Google Patents
Substituierte imidazopyrimidine zur prävention und behandlung von krebsInfo
- Publication number
- ATE380816T1 ATE380816T1 AT04763583T AT04763583T ATE380816T1 AT E380816 T1 ATE380816 T1 AT E380816T1 AT 04763583 T AT04763583 T AT 04763583T AT 04763583 T AT04763583 T AT 04763583T AT E380816 T1 ATE380816 T1 AT E380816T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- cancer
- treatment
- prevention
- substituted imidazopyrimidines
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 150000005237 imidazopyrimidines Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 230000002113 chemopreventative effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 150000003463 sulfur Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301906 | 2003-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380816T1 true ATE380816T1 (de) | 2007-12-15 |
Family
ID=34130555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04763583T ATE380816T1 (de) | 2003-07-30 | 2004-07-29 | Substituierte imidazopyrimidine zur prävention und behandlung von krebs |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060189631A1 (https=) |
| EP (1) | EP1660500B1 (https=) |
| JP (1) | JP2007500160A (https=) |
| KR (1) | KR20060034303A (https=) |
| CN (1) | CN1860121A (https=) |
| AT (1) | ATE380816T1 (https=) |
| AU (1) | AU2004263297A1 (https=) |
| BR (1) | BRPI0412636A (https=) |
| CA (1) | CA2534292A1 (https=) |
| DE (1) | DE602004010680T2 (https=) |
| EA (1) | EA009038B1 (https=) |
| ES (1) | ES2298798T3 (https=) |
| WO (1) | WO2005014598A1 (https=) |
| ZA (1) | ZA200601706B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007096764A2 (en) * | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
| US7683060B2 (en) | 2006-08-07 | 2010-03-23 | Incyte Corporation | Triazolotriazines as kinase inhibitors |
| ME02372B (me) | 2006-11-22 | 2016-06-20 | Incyte Holdings Corp | Imidazotriazini i imidazopiramidini kao inhibitori kinaze |
| EP2062893A1 (en) * | 2007-10-18 | 2009-05-27 | Bayer Schering Pharma AG | Fused imidazoles for cancer treatment |
| UY31292A1 (es) * | 2007-08-14 | 2009-03-31 | Imidazoles biciclicos fusionados | |
| WO2009143211A2 (en) | 2008-05-21 | 2009-11-26 | Incyte Corporation | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| MX2012004341A (es) | 2009-10-16 | 2012-10-05 | Rib X Pharmaceuticals Inc | Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos. |
| EA025304B1 (ru) | 2010-02-03 | 2016-12-30 | Инсайт Холдингс Корпорейшн | ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ |
| US8410117B2 (en) * | 2010-03-26 | 2013-04-02 | Hoffmann-La Roche Inc. | Imidazopyrimidine derivatives |
| SI2694510T1 (sl) | 2011-04-07 | 2016-02-29 | Bayer Intellectual Property Gmbh | Imidazopiridazini kot inhibitorji AKT kinaze |
| CN102796103A (zh) * | 2011-05-23 | 2012-11-28 | 南京英派药业有限公司 | 6-（芳基甲酰）咪唑并[1,2-a]嘧啶和6-（芳基甲酰）[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用 |
| UY35400A (es) * | 2013-03-15 | 2014-10-31 | Novartis Ag | Compuestos y composiciones para el tratamiento de enfermedades parasitarias |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9233961B2 (en) | 2013-03-15 | 2016-01-12 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| TWI674263B (zh) | 2013-12-19 | 2019-10-11 | 瑞士商諾華公司 | 用於治療寄生蟲疾病之化合物及組合物 |
| HK1249758A1 (zh) | 2015-03-11 | 2018-11-09 | Melinta Therapeutics, Inc. | 抗微生物化合物及其制备和使用方法 |
| US11098047B2 (en) | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455924A (en) * | 1967-02-08 | 1969-07-15 | Upjohn Co | Dianisylimidazoles |
| US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| ES2140354B1 (es) * | 1998-08-03 | 2000-11-01 | S A L V A T Lab Sa | Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2. |
-
2004
- 2004-07-29 EP EP04763583A patent/EP1660500B1/en not_active Expired - Lifetime
- 2004-07-29 DE DE602004010680T patent/DE602004010680T2/de not_active Expired - Fee Related
- 2004-07-29 KR KR1020067001923A patent/KR20060034303A/ko not_active Withdrawn
- 2004-07-29 EA EA200600330A patent/EA009038B1/ru not_active IP Right Cessation
- 2004-07-29 AT AT04763583T patent/ATE380816T1/de not_active IP Right Cessation
- 2004-07-29 BR BRPI0412636-0A patent/BRPI0412636A/pt not_active IP Right Cessation
- 2004-07-29 CN CNA2004800279669A patent/CN1860121A/zh active Pending
- 2004-07-29 WO PCT/EP2004/008476 patent/WO2005014598A1/en not_active Ceased
- 2004-07-29 ES ES04763583T patent/ES2298798T3/es not_active Expired - Lifetime
- 2004-07-29 ZA ZA200601706A patent/ZA200601706B/en unknown
- 2004-07-29 CA CA002534292A patent/CA2534292A1/en not_active Abandoned
- 2004-07-29 JP JP2006521521A patent/JP2007500160A/ja not_active Withdrawn
- 2004-07-29 AU AU2004263297A patent/AU2004263297A1/en not_active Abandoned
-
2006
- 2006-01-27 US US11/340,856 patent/US20060189631A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA009038B1 (ru) | 2007-10-26 |
| DE602004010680T2 (de) | 2009-01-02 |
| ZA200601706B (en) | 2007-09-26 |
| BRPI0412636A (pt) | 2006-09-26 |
| EP1660500A1 (en) | 2006-05-31 |
| JP2007500160A (ja) | 2007-01-11 |
| WO2005014598A1 (en) | 2005-02-17 |
| EA200600330A1 (ru) | 2006-08-25 |
| KR20060034303A (ko) | 2006-04-21 |
| AU2004263297A1 (en) | 2005-02-17 |
| DE602004010680D1 (de) | 2008-01-24 |
| US20060189631A1 (en) | 2006-08-24 |
| ES2298798T3 (es) | 2008-05-16 |
| EP1660500B1 (en) | 2007-12-12 |
| CN1860121A (zh) | 2006-11-08 |
| CA2534292A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380816T1 (de) | Substituierte imidazopyrimidine zur prävention und behandlung von krebs | |
| SE0303180D0 (sv) | Novel compounds | |
| MXPA03011484A (es) | Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades. | |
| SE0302232D0 (sv) | Novel Compounds | |
| BG108650A (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| ZA200309887B (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
| DE60226912D1 (de) | Chinolin- und Chianzolinderivate zur Behandlung von Tumoren | |
| BR0314688A (pt) | Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina | |
| CY1110742T1 (el) | Αναστολεις ινδαζολης, βενζισοξαζολης, και βενζισοθειαζολης | |
| NO20032801L (no) | Tiazolderivater for behandling av PPAR-relaterte forstyrrelser | |
| EA200600317A1 (ru) | Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты) | |
| ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
| BRPI0417543A (pt) | quinolinas úteis no tratamento de doença cardiovascular | |
| TW200510317A (en) | Caspase inhibitors and uses thereof | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
| DE60239711D1 (de) | Substituierte Carbostyrilderivate als 5-HT1A-Subtyp Agonisten zur Behandlung von bipolarer Störung | |
| CY1111432T1 (el) | Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5 | |
| ATE359283T1 (de) | Substituierte pyrazinonverbindungen zur behandlung von entzündungen | |
| ATE516031T1 (de) | Verbindungen gegen krebs | |
| GB0412314D0 (en) | Compounds | |
| ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |